デフォルト表紙
市場調査レポート
商品コード
1405849

IVD(体外診断)用酵素の市場規模、シェア、動向分析レポート:酵素タイプ別、疾患タイプ別、技術タイプ別、最終用途別、地域別、セグメント別予測、2023年~2030年

In-vitro Diagnostics Enzymes Market Size, Share & Trends Analysis Report By Enzyme Type (Polymerase & Transcriptase, Proteases), By Disease Type, By Technology Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 199 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
IVD(体外診断)用酵素の市場規模、シェア、動向分析レポート:酵素タイプ別、疾患タイプ別、技術タイプ別、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年12月12日
発行: Grand View Research
ページ情報: 英文 199 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

IVD(体外診断)用酵素市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界のIVD(体外診断)用酵素市場規模は、2023年から2030年にかけてCAGR 7.9%で拡大し、2030年には37億米ドルに達する見込みです。

臨床疾患の正確で迅速な診断と治療は、最適な臨床結果を得るために不可欠です。注目すべき生体触媒特性により、酵素は幅広い疾患の診断に使用されています。

酵素バイオセンサーの開発は、臨床診断における酵素の有用性を高めています。臨床診断における必要性にもかかわらず、バイオセンサーの商業化と研究から臨床への移行はまだ低いです。しかし、研究開発努力の増加に伴い、乳酸、コレステロール、グルコースバイオセンサーが診断用に製品化されています。

プロテアーゼは重要なシグナル伝達タンパク質であり、がん、神経疾患、炎症性疾患、心血管疾患など、いくつかの病理学的プロセスに不可欠です。ポリメラーゼとトランスクリプターゼ酵素は、予測期間中に最も速いCAGRを示すと予想されます。さらに、これらの酵素を提供するプレーヤーが多数存在することが、成長を促進すると予想されます。Kaneka Eurogentec S.A.、東洋紡株式会社、Sekisui Diagnostics, LLCなどの主要企業は、KOD DNA Polymerase、Taq DNA Polymerase、Tth DNA Polymerase、TTx DNA Polymeraseなど、幅広い種類のポリメラーゼを製造・販売しています。

2019年は感染症分野が市場を独占しました。COVID-19症例の世界の急激な増加が、COVID-19診断用診断酵素の採用率を押し上げています。感染症診断のためのリアルタイムPCR、LAMP-PCR(Loop-mediated Isothermal Amplification-PCR)、マルチプレックスPCR、デジタルPCR技術に基づく定性的および定量的分子アッセイの利用可能性の増加が、このセグメントにおける酵素の需要を促進しています。

酵素免疫組織化学(IHC)は、より優れたコントラスト比と、標的成分の検出のために複数のステインと使用できる手法の互換性により、組織学に好まれています。体外診断用医薬品(IVD)酵素は、組織検体や体液の分析のために、さまざまな最終用途で使用されています。一日に複数の分析を行う大規模ラボや、少数の検査を行う小規模クリニックなど、幅広いエンドユーザーが体外診断(IVD)用酵素を使用しています。

北米は2019年、顕著な地域市場として浮上しました。がん患者数の増加や生検サンプルの病理組織検査への酵素の採用は、同地域の市場成長を促進すると予想される他の要因の一部です。対象人口の多さ、ヘルスケアインフラの改善、アンメット・クリニカル・ニーズの高さ、政府のイニシアチブの増加、高度診断技術のための研究開発活動の増加は、アジア太平洋市場を最も速い成長率で牽引すると予測されています。

同市場の主要企業は、市場での存在感を高めるため、新製品の発売、買収、提携、パートナーシップ、地理的拡大などに取り組んでいます。例えば、2020年6月、Codexis, Inc.はAlphazyme LLCと高忠実度DNAポリメラーゼ、T7 RNAポリメラーゼ、逆転写酵素の製造と共同販売に関する提携契約を締結しました。

IVD(体外診断)用酵素市場レポートハイライト

  • 酵素タイプ別では、ポリメラーゼと転写酵素が、分子診断アッセイへの幅広い応用により、2022年に最大のシェアを占めました。
  • 疾患タイプ別では、感染症分野が予測期間を通じて市場を独占すると予測されます。
  • 技術タイプ別では、がん診断における組織学的アッセイの有用性と、さまざまながん種の罹患率の上昇により、組織学的アッセイセグメントが2022年に最大のシェアを占めました。
  • 最終用途別では、病院と診断ラボが2022年の市場を独占しました。これらの施設では、入院患者の増加やがん患者の入院数の増加により、組織病理学や細胞病理学のための生検検体の流入が多いです。
  • 北米は、Innovative Research、Bio-Rad Laboratories, Inc.、Rockland Immunochemicals, Inc.、MyBioSource.com、RayBiotech, Inc.など、この地域にかなりの数のプレーヤーが存在するため、2022年に市場全体を支配しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 IVD(体外診断)用酵素市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • IVD(体外診断)用酵素市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 IVD(体外診断)用酵素:製品の推定・動向分析

  • IVD(体外診断)用酵素市場:重要なポイント
  • IVD(体外診断)用酵素市場:動向と市場シェア分析、2022年および2030年
  • プロテアーゼ
  • ポリメラーゼと転写酵素
  • リボヌクレアーゼ
  • その他

第5章 IVD(体外診断)用酵素:疾患タイプの推定・動向分析

  • IVD(体外診断)用酵素市場:重要なポイント
  • IVD(体外診断)用酵素市場:動向と市場シェア分析、2022年および2030年
  • 感染症
  • 糖尿病
  • 腫瘍学
  • 心臓病学
  • 腎臓学
  • 自己免疫疾患
  • その他

第6章 IVD(体外診断)用酵素:技術の推定・動向分析

  • IVD(体外診断)用酵素市場:重要なポイント
  • IVD(体外診断)用酵素市場:動向と市場シェア分析、2022年および2030年
  • 組織学アッセイ
  • 分子診断学
  • 臨床化学

第7章 IVD(体外診断)用酵素:最終用途の推定・動向分析

  • IVD(体外診断)用酵素市場:重要なポイント
  • IVD(体外診断)用酵素市場:動向と市場シェア分析、2022年および2030年
  • 製薬およびバイオテクノロジー
  • 病院および診断研究所
  • 学術研究室

第8章 IVD(体外診断)用酵素市場:地域の推定・動向分析

  • 地域別の見通し
  • 地域別のIVD(体外診断)用酵素市場:主要なマーケットプレースのポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Merck KGaA
    • Codexis, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Amano Enzymes Inc.
    • Advanced Enzymes Technologies Ltd.
    • Biocatalysts Ltd.
    • Amicogen
    • Dyadic International
    • BBI Solutions
    • Affymetrix
    • American Laboratories
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 3 North America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 4 North America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 5 North America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 8 U.S. in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 9 U.S. in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 10 U.S. in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 12 Canada in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 13 Canada in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 14 Canada in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 16 Europe in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 17 Europe in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 18 Europe in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 21 Germany in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 22 Germany in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 23 Germany in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 25 UK in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 26 UK in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 27 UK in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 29 France in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 30 France in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 31 France in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 33 Italy in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 34 Italy in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 35 Italy in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 37 Spain in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 38 Spain in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 39 Spain in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Sweden in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 41 Sweden in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 42 Sweden in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 43 Sweden in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Norway in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 45 Norway in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 46 Norway in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 47 Norway in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Denmark in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 49 Denmark in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 50 Denmark in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 51 Denmark in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 57 China in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 58 China in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 59 China in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 60 China in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 61 Japan in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 62 Japan in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 63 Japan in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 64 Japan in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 66 India in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 67 India in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 68 India in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Australia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 70 Australia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 71 Australia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 72 Australia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Thailand in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 74 Thailand in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 75 Thailand in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 76 Thailand in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 78 South Korea in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 79 South Korea in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 80 South Korea in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 82 Latin America in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 83 Latin America in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 84 Latin America in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 87 Brazil in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 88 Brazil in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 89 Brazil in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 91 Mexico in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 92 Mexico in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 93 Mexico in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 95 Argentina in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 96 Argentina in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 97 Argentina in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa in-vitro diagnostics enzymes market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 104 South Africa in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 105 South Africa in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 106 South Africa in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 112 UAE in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 113 UAE in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 114 UAE in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait in-vitro diagnostics enzymes market, by enzymes type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait in-vitro diagnostics enzymes market, by disease type, 2018 - 2030 (USD Million)
  • Table 117 Kuwait in-vitro diagnostics enzymes market, by technology type, 2018 - 2030 (USD Million)
  • Table 118 Kuwait in-vitro diagnostics enzymes market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 In-vitro diagnostics enzymes: Market outlook
  • Fig. 9 In-vitro diagnostics enzymes: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 In-vitro diagnostics enzymes market driver impact
  • Fig. 15 In-vitro diagnostics enzymes market restraint impact
  • Fig. 16 In-vitro diagnostics enzymes market strategic initiatives analysis
  • Fig. 17 In-vitro diagnostics enzymes market: Enzyme type movement analysis
  • Fig. 18 In-vitro diagnostics enzymes market: Enzyme type outlook and key takeaways
  • Fig. 19 Proteases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Polymerase & transcriptase market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Ribonuclease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 In-vitro diagnostics enzymes market: Disease type movement analysis
  • Fig. 24 In-vitro diagnostics enzymes market: Disease type outlook and key takeaways
  • Fig. 25 Infectious disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiology market estimates and forecasts, 2018 - 2030
  • Fig. 29 Nephrology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Autoimmune diseases market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 In-vitro diagnostics enzymes market: Technology type movement analysis
  • Fig. 33 In-vitro diagnostics enzymes market: Technology type outlook and key takeaways
  • Fig. 34 Histology assays market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Molecular diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Clinical chemistry market estimates and forecasts, 2018 - 2030
  • Fig. 37 Others market estimates and forecasts, 2018 - 2030
  • Fig. 38 In-vitro diagnostics enzymes market: End use type movement analysis
  • Fig. 39 In-vitro diagnostics enzymes market: End use type outlook and key takeaways
  • Fig. 40 Pharma & biotech market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Hospital & diagnostic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Contract Research Organizations (CROs) market estimates and forecasts, 2018 - 2030
  • Fig. 43 Academic labs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Global in-vitro diagnostics enzymes market: Regional movement analysis
  • Fig. 45 Global in-vitro diagnostics enzymes market: Regional outlook and key takeaways
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68039-246-6

In-vitro Diagnostics Enzymes Market Growth & Trends:

The global in-vitro diagnostics enzymes market size is expected to reach USD 3.70 billion by 2030, expanding at a CAGR of 7.9% from 2023 to 2030, according to a new report by Grand View Research, Inc. Accurate and rapid diagnosis and treatment of clinical disorders are essential for optimal clinical outcomes. Owing to the noteworthy biocatalytic properties, enzymes are used in the diagnosis of a wide range of diseases.

The development of enzyme biosensors has increased the enzyme utility in clinical diagnostics. Despite the necessity in clinical diagnosis, the commercialization and translation of biosensors from research to clinics are still low. However, with an increase in R&D efforts, lactate, cholesterol, and glucose biosensors have been commercialized for diagnostic use.

Proteases are important signaling proteins that are critical to a few pathological processes, including cancer, neurological, inflammatory, and cardiovascular disorders. Polymerase and transcriptase enzymes are expected to exhibit the fastest CAGR over the forecast period. In addition, the presence of a substantial number of players that offer these enzymes is expected to enhance the growth. Key players such as Kaneka Eurogentec S.A.; Toyobo Co., Ltd.; and Sekisui Diagnostics, LLC manufacture and distribute a wide range of polymerases, including KOD DNA Polymerase, Taq DNA Polymerase, Tth DNA Polymerase, and TTx DNA Polymerase.

The infectious disease segment dominated the market in 2019. An exponential rise in the COVID-19 cases globally drives the adoption rate of diagnostic enzymes for COVID-19 diagnosis. An increase in the availability of qualitative and quantitative molecular assays based on real-time PCR, Loop-mediated Isothermal Amplification- PCR (LAMP-PCR), multiplex PCR, and digital PCR technologies for the diagnosis of infectious diseases drives the demand for enzymes in this segment.

Enzymatic immunohistochemistry (IHC) is preferred for histology owing to a better contrast ratio and the method's compatibility for use with multiple stains for the detection of target components. IVD enzymes are employed in different end-use settings for the analysis of tissue specimens and bodily fluids. A wide range of end users including large laboratories that conduct multiple analyses in a day and smaller clinics that conduct a few tests use enzymes for in-vitro diagnostics (IVD).

North America emerged as a prominent regional market in 2019. A rise in the number of cancer cases and the adoption of enzymes for histopathology of biopsy samples are some of the other factors expected to propel market growth in the region. The presence of a large target population, improvements in healthcare infrastructure, high unmet clinical needs, increase in government initiatives, and rise in R&D activities for advanced diagnostic techniques are anticipated to drive the Asia Pacific market with the fastest growth rate.

The key players in the market are involved in novel product launches, acquisitions, collaborations, partnerships, and geographical expansions to reinforce their market presence. For instance, in June 2020, Codexis, Inc. signed a collaboration agreement with Alphazyme LLC for the manufacture and co-marketing of high-fidelity DNA polymerase, T7 RNA polymerase, and reverse transcriptase.

In-vitro Diagnostics Enzymes Market Report Highlights:

  • By enzyme type, polymerase and transcriptase enzymes held the largest share in 2022 owing to their wide applications in molecular diagnostic assays
  • Based on disease type, the infectious disease segment is expected to dominate the market throughout the forecast period
  • In terms of technology type, the histology assays segment held the largest share in 2022 owing to the utility of histology assays in cancer diagnostics, coupled with a rising incidence of different cancer types
  • By end use, hospital and diagnostic labs dominated the market in 2022. They witness a high inflow of biopsy specimens for histopathology and cytopathology because of an increase in hospitalization and rise in the number of hospital admissions for cancer patients
  • North America dominated the overall market in 2022 owing to the presence of a substantial number of players in this region including Innovative Research; Bio-Rad Laboratories, Inc.; Rockland Immunochemicals, Inc.; MyBioSource.com; and RayBiotech, Inc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Enzyme Type
    • 1.1.2. Disease Type
    • 1.1.3. Technology Type
    • 1.1.4. End use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Enzyme type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Technology type outlook
    • 2.2.4. End use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. In-Vitro Diagnostics Enzymes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. In-Vitro Diagnostics Enzymes Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. In-Vitro Diagnostics Enzymes: Product Estimates & Trend Analysis

  • 4.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 4.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Proteases
    • 4.3.1. Proteases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Polymerase & Transcriptase
    • 4.4.1. Polymerase & Transcriptase market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Ribonuclease
    • 4.5.1. Ribonuclease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. In-Vitro Diagnostics Enzymes: Disease Type Estimates & Trend Analysis

  • 5.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 5.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Infectious Disease
    • 5.3.1. Infectious Disease market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.1. COVID -19 Testing
      • 5.3.1.1.1. COVID-19 testing market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.2. Hepatitis
      • 5.3.1.2.1. Hepatitis market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.3. HIV
      • 5.3.1.3.1. HIV market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Other testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Diabetes
    • 5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Oncology
    • 5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cardiology
    • 5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Nephrology
    • 5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Autoimmune Diseases
    • 5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. In-Vitro Diagnostics Enzymes: Technology Estimates & Trend Analysis

  • 6.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 6.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Histology Assays
    • 6.3.1. Histology Assays market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Molecular diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.1. PCR Assays
      • 6.4.1.1.1. PCR assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.2. NGS Assays
      • 6.4.1.2.1. NGS assays market estimates and forecasts, 2018 to 2030 (USD Million)
      • 6.4.1.3. Others
      • 6.4.1.3.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Chemistry
    • 6.5.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. In-Vitro Diagnostics Enzymes : End Use Estimates & Trend Analysis

  • 7.1. In-Vitro Diagnostics Enzymes Market: Key Takeaways
  • 7.2. In-Vitro Diagnostics Enzymes Market: Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Pharma & Biotech
    • 7.3.1. Pharma & Biotech market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Hospital & Diagnostic Labs
    • 7.4.1. Hospital & Diagnostic Lab market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Academic Labs
    • 7.5.1. Academic Lab market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. In-Vitro Diagnostics Enzymes Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. In-Vitro Diagnostics Enzymes Market by Region: Key Marketplace Takeaway
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. U.K.
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Sweden
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Norway
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. Saudi Arabia
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Merck KGaA
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. Codexis, Inc.
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. F. Hoffmann-La Roche Ltd.
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Amano Enzymes Inc.
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Advanced Enzymes Technologies Ltd.
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. Biocatalysts Ltd.
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. Amicogen
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Dyadic International
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. BBI Solutions
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. Affymetrix
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. American Laboratories
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives